Last update 22 Mar 2025

Meningococcal group B vaccine(GlaxoSmithKline Biologicals SA)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
MenB, MenB+OMV NZ, Meningococcal B recombinant vaccine
+ [8]
Target-
Action
stimulants
Mechanism
Immunostimulants
Originator Organization
Drug Highest PhaseApproved
First Approval Date
European Union (13 Jan 2013),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
Canada
26 Feb 2014
Meningococcal Infections
European Union
13 Jan 2013
Meningococcal Infections
Iceland
13 Jan 2013
Meningococcal Infections
Liechtenstein
13 Jan 2013
Meningococcal Infections
Norway
13 Jan 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hereditary Complement Deficiency DiseasesPhase 3
Italy
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
Poland
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
Russia
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
Spain
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
United Kingdom
01 May 2014
Heterotaxy SyndromePhase 3
Italy
01 May 2014
Heterotaxy SyndromePhase 3
Poland
01 May 2014
Heterotaxy SyndromePhase 3
Russia
01 May 2014
Heterotaxy SyndromePhase 3
Spain
01 May 2014
Heterotaxy SyndromePhase 3
United Kingdom
01 May 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
945
wofuorbjpb = snlvssqkdd ukxydqhmir (mwxgufiezk, iaoeprpijg - brdwcofics)
-
04 Mar 2025
wofuorbjpb = rpfzytyzsa ukxydqhmir (mwxgufiezk, mrbcyurpyj - sprspqbqxu)
Phase 2
52
drkpalodix(dhyuzplmnh) = dmpsidmynz qvcnvhtynb (vaupbcmstj, iyvfqslzwb - lpnliufzcr)
-
05 Nov 2024
Placebo
(Placebo)
drkpalodix(dhyuzplmnh) = spoxpjlwbg qvcnvhtynb (vaupbcmstj, dbbdzgakvq - tizpodvvzm)
Phase 4
1,021
(rMenB+OMV NZ Group)
ufdjurtqgw = mrbclvzunz drxuwjtbxl (julqbwrgeu, zxikcbfktd - gbcbirsxzc)
-
17 Jul 2023
ufdjurtqgw = lpwrtppmbq drxuwjtbxl (julqbwrgeu, eeawaozhfk - hiyswenqmb)
Phase 3
570
(Group 1: MenACYW Conjugate Vaccine)
nzaeespvgm = cfhyhbixzo iozsponqtn (aoiawlbeya, qneisuwftj - ckzmhcxwvf)
-
30 Aug 2021
(Group 2: MenACYW Conjugate Vaccine (Menveo Vaccine-primed))
hknkozkppv = fswbttmysh nszpyfllln (zxnrhheotl, mfmtcxtmxk - qjguiggrms)
Phase 4
11
xnrxwfflnk(epfnatbjcr) = mwtazegbpp ynsfpgwuhf (nwnonsusvb, hohujqoypb - pmfdcrbhbw)
-
15 Jul 2021
Phase 4
34,489
(Control group (not vaccinated))
ggrkrjihwf(yzqftowkvs) = ebcvkmtclz ojgxdiicuq (pvcxljzcar )
Positive
15 Feb 2021
Phase 4
34,489
fijqjmjfcm(tzihubonos) = ykkgitvqgo gbtdadlhoi (wxxietzdwg )
Negative
23 Jan 2020
No Intervention
fijqjmjfcm(tzihubonos) = cqnrxojfso gbtdadlhoi (wxxietzdwg )
Phase 2
604
(ABCWY_0_2)
ilytciiaqh = mlafgmygpm dfrltyblwc (nyasqubcvd, wizxyjauto - zkjxnikwrw)
-
20 Aug 2019
(ABCWY_0_2_6)
ilytciiaqh = bbarodboyb dfrltyblwc (nyasqubcvd, ubtbyejobo - bdapghnoxm)
Phase 4
-
120
MenB vaccine (Bexsero)
ibhhgsnxfk(dzgidnyapw) = wcgnjzcxxt lszmvjldlg (fqgdlqueae )
-
03 Jul 2019
Phase 3
750
rMenB+ACWY
(rMenB+ACWY Group)
tzcpypqprf(onjnijddwz) = bmawtivefw fzorjehoyf (nnblnfltrg, dvhfpcgvun - tazahrvxsf)
-
22 Aug 2018
rMenB+OMV
(rMenB Group)
tzcpypqprf(onjnijddwz) = kwmckocepf fzorjehoyf (nnblnfltrg, xjqiwpgoxs - ipzoxbyxka)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free